Results 251 to 260 of about 17,768 (339)

Structure–activity analysis of imino‐pyrimidinone‐fused pyrrolidines aids the development of dual plasmepsin V and plasmepsin X inhibitors

open access: yesThe FEBS Journal, EarlyView.
Compounds were identified that inhibit the aspartic protease plasmepsin V from Plasmodium vivax. Further development of these compounds identified compounds, such as S‐WM48, that could inhibit both plasmepsin V and plasmepsin X but plasmepsin IX was not significantly inhibited.
Anthony N. Hodder   +11 more
wiley   +1 more source

Borohydride Oxidation as Counter Reaction in Reductive Electrosynthesis

open access: yesAngewandte Chemie, Volume 137, Issue 20, May 12, 2025.
Herein, anodic borohydride oxidation is demonstrated to have great potential for successfully replacing sacrificial metal anodes in a variety of electroreductive organic transformations. This anodic counter reaction effectively serves as the inverse of cathodic proton reduction, producing H2 at inert carbon‐based electrode materials.
Julius Kuzmin   +6 more
wiley   +2 more sources

A pyrrolidine-based specific inhibitor of cytosolic phospholipase A2α blocks arachidonic acid release in a variety of mammalian cells

open access: bronze, 2001
Farideh Ghomashchi   +6 more
openalex   +1 more source

Dual ETA‐ETB receptor antagonism improves metabolic syndrome‐induced heart failure with preserved ejection fraction

open access: yesFundamental &Clinical Pharmacology, Volume 39, Issue 3, June 2025.
Abstract Background Metabolic syndrome (MetS) is a multifaceted disease associated with heart failure (HF), which affects the vascular system. The endothelin (ET) system is a key player in MetS and HF; therefore, targets for ET receptors are of therapeutic interest.
Francesca Lockwood   +11 more
wiley   +1 more source

Scalable Synthesis of Biologically Relevant Spirocyclic Pyrrolidines

open access: yesACS Omega, 2019
Kostiantyn P. Melnykov   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy